DIGA PHARMACEUTICAL GROUP SHARESLimited Company

Rivaroxaban and impuritiesA ReferenceProjectTender Notice

Basic information of 1. project

1. Project (material) name:RivaroxabanEP Standard Test Reference

2. Location of demand:DEGA Quality Inspection Center

3. Demand overview: 

rivaroxaban control Manufacturer:EP100mg per Y0002187

rivaroxaban impurityA reference substance manufacturer: EP5mg per Y0002188

5. Time limit requirements:Completed before 2024.06.29

6. Other requirements:

2. Supplier Qualification Requirements

1. A valid business license shall be provided for a legal person or other organization registered in the People's Republic of China.

2Must have the ability to bear civil liability independently.

3Must have a good business reputation and a sound financial accounting system, and be able to issue special VAT invoices.

4, must haveA good record of paying taxes and social security funds in accordance with the law within 3 years, and no major illegal records in business activities.

5, must have the necessary equipment and professional and technical capabilities to perform the project. Relevant supporting materials (including but not limited to professional qualifications, past successful cases and contracts) shall be provided.

6. Other conditions stipulated by laws and regulations.

3. Registration Instructions

1. This tender invitation announcement shall end on [June] [20] of [2024] and will not be accepted within the time limit.

2. If you are interested in participating, please sort out the above information (seal) before the deadline for announcement,Send as maildijiazbb@163.com；

Note: Please unify the mailtoName "Project Name Bidding Unit Name Preliminary Quotation". Please leave "Unit Contact Person, Position and Contact Information" (not less than two) in the body of the email.

3. Telephone number for consultation: 【0631-3857033】

4. After examination of qualified registration units, our staff will send detailed bidding documents by mail. Please check the mailbox in time. If you receive any, please reply and confirm by mail.

4. supervision and reporting methods

1. Report telephone number:0631-3855888

2. Report mailbox:zhengquanbu@dijiagroup.com

5. Other

The final interpretation of this tender belongs to our company. Please pay attention to the feedback information received by phone or email.